Zydus receives final approval from USFDA for Methenamine Hippurate Tablets USP, 1 gram
(MENAFN- Adfactors PR) Bengaluru, 12 March, 2025
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram (USRLD: Hiprex® Tablets, 1 gram).
Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. Methenamine Hippurate tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad.
Methenamine Hippurate tablets had annual sales of USD 32.6 mn in the United States (IQVIA MAT January 2025).
The group now has 419 approvals and has so far filed 483* ANDAs since the commencement of the filing process in FY 2003-04.
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram (USRLD: Hiprex® Tablets, 1 gram).
Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. Methenamine Hippurate tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad.
Methenamine Hippurate tablets had annual sales of USD 32.6 mn in the United States (IQVIA MAT January 2025).
The group now has 419 approvals and has so far filed 483* ANDAs since the commencement of the filing process in FY 2003-04.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
- What Does The Europe Cryptocurrency Market Report Reveal For 2025?
- United States Kosher Food Market Long-Term Growth & Forecast Outlook 20252033
- Utila Triples Valuation In Six Months As Stablecoin Infrastructure Demand Triggers $22M Extension Round
- Meme Coin Little Pepe Raises Above $24M In Presale With Over 39,000 Holders
- FBS Analysis Highlights How Political Shifts Are Redefining The Next Altcoin Rally
- 1Inch Becomes First Swap Provider Relaunched On OKX Wallet
More Story
Comments
No comment